FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Within the proposed single arm multicenter phase-II trial it is intended to investigate the feasi-bility of adding Avelumab to FOLFIRI plus Cetuximab after 4 cycles (2 months) of treatment with FOLFIRI plus Cetuximab. After 4 more cycles of FOLFIRI plus Cetuximab plus Avelumab the treatment will be de-escalated to Avelumab as a maintenance concept until progression of the disease according to RECIST 1.1 has occurred.
创建时间：
2019-09-15
